Immunis

Developer of cell therapies for age-related and disease-related immune deficits

placeIrvine, California, United States calendar_todayFounded 2018 groups3 employees language immunisbiomedical.com

Registered entities

Social engagement

Social engagement: 2.5K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Remiges Ventures.

Investor typeCountShare
Venture capital6100%

Recent activity

26 Jun 2026
Event
RESI San Diego's Innovator's Pitch Challenge
25 Jun 2026
Product launch
Multi-active biologics
3 Jun 2026
Event
Innovator's Pitch Challenge
Coming soon